HDLB: linked to the Solactive US High Dividend Low Volatility Index
SMHB: linked to the Solactive US Small Cap High Dividend Index
PFFL: linked to the Solactive Preferred Stock ETF Index
CEFD: linked to the S-Network Composite Closed-End Fund Index
MVRL: linked to the MVIS US Mortgage REITs Index
GLDI: linked to the Nasdaq Gold FLOWSTM 103 Index
SLVO: linked to the Nasdaq Silver FLOWSTM 106 Index
USOI: linked to the Nasdaq WTI Crude Oil FLOWSTM 106 Index
New York, December 4, 2025 – UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the “ETNs”).
NYSE Ticker | ETN Name and Prospectus Supplementa | Coupon Valuation Date | Ex-Date | Record Date | Payment Date | Coupon Amount | Payment Schedule | Current Yield (annualized) b | |||||||||
HDLB | ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B | 12/01/2025 | 12/12/2025 | 12/12/2025 | 12/22/2025 | $0.1745 | Monthly | 12.52% | |||||||||
SMHB | ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B | 12/01/2025 | 12/12/2025 | 12/12/2025 | 12/22/2025 | $0.0422 | Monthly | 19.76% | |||||||||
PFFL | ETRACS 2xMonthly Pay Leveraged Preferred Stock ETN | 12/01/2025 | 12/12/2025 | 12/12/2025 | 12/22/2025 | $0.1368 | Monthly | 13.39% | |||||||||
CEFD | 12/01/2025 | 12/12/2025 | 12/12/2025 | 12/22/2025 | $0.2210 | Monthly | 14.36% | ||||||||||
MVRL | 12/01/2025 | 12/12/2025 | 12/12/2025 | 12/22/2025 | $0.1670 | Monthly | 18.58% |
NASDAQ Ticker | ETN Name and Pricing Supplementc | Closing Indicative Value on 11/28/2025 | Ex-Date | Record Date | Payment Date | ExpectedCoupon Amount per ETNd | Payment Schedule | Expected Current Yielde | |||||||||
GLDI | $172.6384 | 12/22/2025 | 12/22/2025 | 12/29/2025 | $3.2409 | Monthly | 18.63%f | ||||||||||
SLVO | $97.4570 | 12/22/2025 | 12/22/2025 | 12/29/2025 | $2.6875 | Monthly | 27.82%f | ||||||||||
USOI | ETRACS Crude Oil Shares Covered Call ETNs due April 24, 2037 | $48.8447 | 12/22/2025 | 12/22/2025 | 12/29/2025 | $0.6282 | Monthly | 16.17%f |
Cautionary Statement Regarding Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements” that are subject to risks and uncertainties, and actual results may differ materially. These statements could contain words such as “possible,” “intend,” “will,” “may,” “intends,” “would,” “if,” “expect,” “potentially” or other similar expressions. Forward-looking statements, including those relating to UBS AG’s plans for the ETNs, are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. While these forward-looking statements represent UBS’s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors, including whether UBS AG will actually declare a Coupon Amount for the 3 ETNs traded on NASDAQ, could cause actual developments and results to differ materially from UBS’s expectations. For a discussion of the risks and uncertainties that may affect the ETNs please refer to the "Risk Factors" in the prospectus supplements and pricing supplement relating to the 3 ETNs traded on NASDAQ. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.
About ETRACS
ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on either NYSE Arca or NASDAQ, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the ETNs. We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement for the ETRACS ETN.
UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the relevant prospectus, along with the applicable prospectus supplement and pricing supplements to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS ETNs. The applicable offering document for each ETRACS ETN may be obtained by clicking on the name of each ETRACS ETN identified above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request the prospectus, the applicable prospectus supplement or pricing supplement, by calling toll-free (+1-877-387-2275). The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
Contacts
Contacts
Media contact
Alison Keunen
+1-212-713-2296
alison.keunen@ubs.com
Institutional Investor contact1
+1-877-387-2275
